New York State Common Retirement Fund Vir Biotechnology, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 24,606 shares of VIR stock, worth $197,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,606

Previous 34,006 27.64%

Holding current value

$197,094

Previous $303,000 39.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$7.26 - $10.7 $68,244 - $100,580	-9,400 Reduced 27.64%	24,606 $184,000
Q2 2024 Jul 31, 2024	BUY	$7.63 - $12.66 $5,386 - $8,937	706 Added 2.12%	34,006 $303,000
Q1 2024 May 07, 2024	SELL	$8.6 - $11.9 $6,389 - $8,841	-743 Reduced 2.18%	33,300 $337,000
Q4 2023 Feb 01, 2024	SELL	$7.76 - $10.29 $2,630 - $3,488	-339 Reduced 0.99%	34,043 $342,000
Q3 2023 Nov 07, 2023	SELL	$9.14 - $24.62 $97,048 - $261,415	-10,618 Reduced 23.6%	34,382 $322,000
Q2 2023 Aug 07, 2023	BUY	$23.2 - $27.29 $159,268 - $187,345	6,865 Added 18.0%	45,000 $1.1 Million
Q1 2023 May 02, 2023	SELL	$22.26 - $30.85 $858,902 - $1.19 Million	-38,585 Reduced 50.29%	38,135 $887,000
Q4 2022 Jan 30, 2023	BUY	$19.96 - $28.22 $35,508 - $50,203	1,779 Added 2.37%	76,720 $1.94 Million
Q3 2022 Nov 08, 2022	SELL	$18.26 - $31.1 $84,982 - $144,739	-4,654 Reduced 5.85%	74,941 $1.45 Million
Q2 2022 Aug 04, 2022	BUY	$19.08 - $26.7 $692,184 - $968,622	36,278 Added 83.75%	79,595 $2.03 Million
Q1 2022 May 05, 2022	BUY	$21.19 - $40.01 $572 - $1,080	27 Added 0.06%	43,317 $1.11 Million
Q4 2021 Feb 02, 2022	SELL	$30.97 - $54.03 $4,088 - $7,131	-132 Reduced 0.3%	43,290 $1.81 Million
Q3 2021 Nov 02, 2021	SELL	$34.9 - $54.54 $297,906 - $465,553	-8,536 Reduced 16.43%	43,422 $1.89 Million
Q2 2021 Aug 02, 2021	BUY	$38.75 - $51.0 $133,997 - $176,358	3,458 Added 7.13%	51,958 $2.46 Million
Q3 2020 Nov 05, 2020	BUY	$28.28 - $53.6 $169,680 - $321,600	6,000 Added 14.12%	48,500 $1.67 Million
Q2 2020 Aug 07, 2020	BUY	$27.89 - $47.86 $956,627 - $1.64 Million	34,300 Added 418.29%	42,500 $1.74 Million
Q4 2019 Feb 05, 2020	BUY	$11.83 - $15.85 $97,006 - $129,970	8,200 New	8,200 $103,000

Others Institutions Holding VIR

# of Institutions

220

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.06B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Vir Biotechnology, Inc. Transaction History